Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
Keywords: STING agonist; PBAE nanoparticle formulation; Cancer immunotherapy; CDNs; Cyclic dinucleotides; STING; Stimulator of Interferon Receptor; PBAEs; poly(beta-amino ester)s; IFN; interferon; SEAP; secreted embryonic alkaline phosphatase; cGAS; cyclic GMP-AMP